Skip to content

Public FDA record

Z-1744-2020: ACUVUE OASYS for ASTIGMATISM Brand Contact Lenses. Lot no. B00NKM0G. Base Curve 8.6, Refractive Power -3.

Recall record Z-1744-2020 for Johnson & Johnson Vision Care, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1744-2020
Company in FDA record
Johnson & Johnson Vision Care, Inc.
FDA record creation date
Apr 17, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Package integrity failure observed during routine shift package integrity testing at an external re-packager.

Source facts

Action
Johnson & Johnson Vision Care Inc., notified customers on 12/18/2017 via Recall Notification letter. Included with the Recall Notification Letter was a Customer Reply Form which the customer is instructed to fax back to the firm.
Initiated
2017-12-18
Root cause
Packaging
Terminated
2020-06-10
Distribution
Nationwide US.
Recall number
Z-1744-2020
Recall status
Terminated
CDRH record ID
180377
FDA record created
2020-04-17
Recall event number
85261

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗